Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Gene Pool: The Ethics of Genetics in Primary Care.

Annual review of nursing research·2015
Same author

Pre- and postassessment of nurse practitioners' knowledge of hereditary colorectal cancer.

Journal of the American Academy of Nurse Practitioners·2011
Same author

Central American mothers report family history of depression and alcohol abuse as a predictor of teenage health risk behaviors.

Journal of the American Academy of Nurse Practitioners·2010
Same author

Breast cancer and the family tree. An issue for all practice settings.

Advance for nurse practitioners·2009
Same author

Breast cancer risk elements and nurse practitioners' knowledge, use, and perceived comfort level of breast cancer risk assessment.

Journal of the American Academy of Nurse Practitioners·2009
Same author

Reducing premature osteoarthritis in the adolescent through appropriate screening.

Journal of pediatric nursing·2009

Related Experiment Video

Updated: Jul 8, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Prostate-specific antigen screening: friend or foe?

Mary Morse Linn1, Robert A Ball, Ann Maradiegue

  • 1Adult Practice Program, George Mason University, Fairfax, VA, USA.

Urologic Nursing
|January 26, 2008
PubMed
Summary

The prostate-specific antigen (PSA) blood test is a common tool for detecting early prostate cancer. However, its effectiveness is debated due to false positives and differing medical recommendations, requiring individualized patient assessment.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Related Experiment Videos

Last Updated: Jul 8, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Area of Science:

  • Oncology
  • Urology
  • Diagnostic Medicine

Background:

  • Prostate cancer is the most common cancer diagnosed in US men.
  • The prostate-specific antigen (PSA) blood test is widely used for early detection.
  • PSA testing is a primary screening method but faces scrutiny regarding its effectiveness and recommendations.

Purpose of the Study:

  • To examine the benefits and detriments of PSA screening for prostate cancer.
  • To highlight the need for understanding PSA test limitations.
  • To emphasize individualized risk assessment in prostate cancer screening protocols.

Main Methods:

  • Review of current literature on PSA screening.
  • Analysis of specificity and false-positive rates of PSA tests.
  • Examination of varying screening recommendations from major health organizations.

Main Results:

  • PSA screening lacks high specificity, leading to frequent false-positive results.
  • Divergent screening recommendations exist among major health organizations.
  • Individualized patient assessment is crucial for effective prostate cancer screening.

Conclusions:

  • Understanding the benefits and drawbacks of PSA testing is essential for both medical professionals and patients.
  • Providers must consider multiple risk factors for personalized prostate cancer screening.
  • The utility of PSA screening necessitates careful consideration of its limitations and patient-specific factors.